HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fair Trade USA Modifies Seal In Line With Ad Board Review

This article was originally published in The Rose Sheet

Executive Summary

For personal-care offerings containing less than 100% fair trade certified ingredients, NARB advises that Fair Trade USA include the “relative percentage by weight of ingredients that are fair trade sourced” on its labels.

You may also be interested in...



Dr. Bronner’s Urges NAD/NARB To Refer Fair Trade USA To Regulators

Unsatisfied with Fair Trade USA’s response to the National Advertising Review Board’s latest ruling, which advised the certifier to require percentage breakdowns for fair-trade ingredients on personal-care products, Dr. Bronner’s Magic Soaps asks that the case be referred to regulatory authorities.

Consumer Perception Key Factor In NARB Fair-Trade Review

In reviewing the National Advertising Division decision on Fair Trade USA’s “Certified Ingredients” logo, the National Advertising Review Board focused on the issue of consumer perception, or “how consumers could reasonably interpret a piece of advertising.” NARB’s conclusion differed from NAD’s, resulting in modifications on Fair Trade USA’s end.

Advertising Board Green-Lights Dr. Bronner’s Appeal Of Fair-Trade Decisions

The National Advertising Review Board will allow Dr. Bronner’s Magic Soaps to appeal the National Advertising Division’s recent decisions regarding fair-trade certifications, according to a recent release.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018286

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel